Literatura académica sobre el tema "Potent anti-cancer agent"
Crea una cita precisa en los estilos APA, MLA, Chicago, Harvard y otros
Consulte las listas temáticas de artículos, libros, tesis, actas de conferencias y otras fuentes académicas sobre el tema "Potent anti-cancer agent".
Junto a cada fuente en la lista de referencias hay un botón "Agregar a la bibliografía". Pulsa este botón, y generaremos automáticamente la referencia bibliográfica para la obra elegida en el estilo de cita que necesites: APA, MLA, Harvard, Vancouver, Chicago, etc.
También puede descargar el texto completo de la publicación académica en formato pdf y leer en línea su resumen siempre que esté disponible en los metadatos.
Artículos de revistas sobre el tema "Potent anti-cancer agent"
Bhat, Smitha S., Shashanka K. Prasad, Chandan Shivamallu, Kollur Shiva Prasad, Asad Syed, Pruthvish Reddy, Charley A. Cull y Raghavendra G. Amachawadi. "Genistein: A Potent Anti-Breast Cancer Agent". Current Issues in Molecular Biology 43, n.º 3 (10 de octubre de 2021): 1502–17. http://dx.doi.org/10.3390/cimb43030106.
Texto completoIbrahim, Mona, Donia Wafaa y Ghada El Nady. "Ginger Extract as Potent Anti-Cancer Agent against Breast Cancer". Journal of Agricultural Chemistry and Biotechnology 13, n.º 12 (1 de diciembre de 2022): 139–43. http://dx.doi.org/10.21608/jacb.2023.183821.1042.
Texto completoSAXENA, B., L. ZHU, M. HAO, E. KISILIS, M. KATDARE, O. OKTEM, A. BOMSHTEYN y P. RATHNAM. "Boc-lysinated-betulonic acid: A potent, anti-prostate cancer agent". Bioorganic & Medicinal Chemistry 14, n.º 18 (15 de septiembre de 2006): 6349–58. http://dx.doi.org/10.1016/j.bmc.2006.05.048.
Texto completoSamuel, Samson, Elizabeth Varghese, Peter Kubatka, Chris Triggle y Dietrich Büsselberg. "Metformin: The Answer to Cancer in a Flower? Current Knowledge and Future Prospects of Metformin as an Anti-Cancer Agent in Breast Cancer". Biomolecules 9, n.º 12 (9 de diciembre de 2019): 846. http://dx.doi.org/10.3390/biom9120846.
Texto completoPurushottamachar, Puranik, Aakanksha Khandelwal, Tadas S. Vasaitis, Robert D. Bruno, Lalji K. Gediya y Vincent C. O. Njar. "Potent anti-prostate cancer agents derived from a novel androgen receptor down-regulating agent". Bioorganic & Medicinal Chemistry 16, n.º 7 (1 de abril de 2008): 3519–29. http://dx.doi.org/10.1016/j.bmc.2008.02.031.
Texto completoSameem, Bilqees, Ebrahim Saeedian Moghadam, Majid Darabi, Zahra Shahsavari y Mohsen Amini. "Triarylpyrazole Derivatives as Potent Cytotoxic Agents; Synthesis and Bioactivity Evaluation “Pyrazole Derivatives as Anticancer Agent”". Drug Research 71, n.º 07 (19 de mayo de 2021): 388–94. http://dx.doi.org/10.1055/a-1498-1714.
Texto completoWatanabe, Coran M. H., Lubica Supekova y Peter G. Schultz. "Transcriptional Effects of the Potent Enediyne Anti-Cancer Agent Calicheamicin γ1I". Chemistry & Biology 9, n.º 2 (febrero de 2002): 245–51. http://dx.doi.org/10.1016/s1074-5521(02)00103-5.
Texto completoTundis, Rosa, Jayanta Kumar Patra, Marco Bonesi, Subrata Das, Rajat Nath, Anupam Das Talukdar, Gitishree Das y Monica Rosa Loizzo. "Anti-Cancer Agent: The Labdane Diterpenoid-Andrographolide". Plants 12, n.º 10 (12 de mayo de 2023): 1969. http://dx.doi.org/10.3390/plants12101969.
Texto completoLiu, Weiya, Eugene K. Lee, Karim Pirani, Brian S. J. Blagg y Jeffrey M. Holzbeierlein. "A new HSP90 inhibitor as therapeutic agent for bladder cancer." Journal of Clinical Oncology 35, n.º 6_suppl (20 de febrero de 2017): 416. http://dx.doi.org/10.1200/jco.2017.35.6_suppl.416.
Texto completoRosenthal, Gerald A. "l-Canaline: A potent antimetabolite and anti-cancer agent from leguminous plants". Life Sciences 60, n.º 19 (abril de 1997): 1635–41. http://dx.doi.org/10.1016/s0024-3205(96)00595-4.
Texto completoTesis sobre el tema "Potent anti-cancer agent"
Afolabi, Fatai. "Synthesis of novel fluorescence cationic gold(I) complexes as potent anti-cancer agent". Thesis, University of Sussex, 2018. http://sro.sussex.ac.uk/id/eprint/80482/.
Texto completoMadadi, Nikhil Reddy. "Synthesis and Biological Evaluation of Novel Resveratrol and Combretastatin A4 Derivatives as Potent Anti-Cancer Agents". UKnowledge, 2014. http://uknowledge.uky.edu/pharmacy_etds/42.
Texto completoCapítulos de libros sobre el tema "Potent anti-cancer agent"
De Pauw, Ines, Carolien Boeckx y An Wouters. "Mechanisms of Cetuximab Resistance and How to Overcome It". En Critical Issues in Head and Neck Oncology, 21–51. Cham: Springer International Publishing, 2021. http://dx.doi.org/10.1007/978-3-030-63234-2_3.
Texto completoFriedman, Paula N., Dana F. Chace, Susan L. Gawlak y Clay B. Siegall. "The Single-Chain Immunotoxins BR96 sFv-PE40 and BR96 sFv-PE38: Potent Anti-Tumor Agents for the Treatment of Human Cancer". En Growth Factors, Peptides and Receptors, 409–14. Boston, MA: Springer US, 1993. http://dx.doi.org/10.1007/978-1-4615-2846-3_39.
Texto completoCheng, Yu-Chen, Yu-Chiang Hung y Wen-Long Hu. "Polyphenols of Salvia miltiorrhiza in Aging-Associated Cardiovascular Diseases and Cancer". En Phenolic Compounds [Working Title]. IntechOpen, 2021. http://dx.doi.org/10.5772/intechopen.98632.
Texto completo"Tripentones: A Promising Series of Potent Anti-Cancer Agents". En Advances in Anticancer Agents in Medicinal Chemistry, editado por Christophe Rochais, Sylvain Rault y Patrick Dallemagne, 313–43. BENTHAM SCIENCE PUBLISHERS, 2013. http://dx.doi.org/10.2174/9781608054961113020009.
Texto completoSadik, Saabira Banu Sahubar, Prathibha Sivaprakasam, Nishanthi Ramasami y Ashok Kumar Pandurangan. "The Molecular Mechanisms Involved in Suppressing Triple Negative Breast Cancer Using Natural Agents". En Handbook of Research on Natural Products and Their Bioactive Compounds as Cancer Therapeutics, 45–71. IGI Global, 2022. http://dx.doi.org/10.4018/978-1-7998-9258-8.ch003.
Texto completoDwarka, Depika, Himansu Baijnath y John Jason Mellem. "Bioactive Compounds as Therapeutic Intervention in Cancer Therapy". En Therapeutic Use of Plant Secondary Metabolites, 84–110. BENTHAM SCIENCE PUBLISHERS, 2022. http://dx.doi.org/10.2174/9789815050622122010007.
Texto completoChauhdary, Zunera, Muhammad Ajmal Shah, Malik Hassan Mehmood, Uzma Saleem, Azhar Rasul, Ghulam Mujtaba Shah, Ajmal Khan, Ahmed Al-Harrasi, Shabnoor Iqbal y Shabana Bibi. "Saponins in the Treatment of Gastrointestinal Tract Cancer". En Phytonutrients in the Treatment of Gastrointestinal Cancer, 159–81. BENTHAM SCIENCE PUBLISHERS, 2023. http://dx.doi.org/10.2174/9789815049633123010010.
Texto completoSarkar, Arnab, Tanmoy Banerjee, Avik Maji, Abhik Paul y Tanmoy Guria. "Mikania Species: Revealing Phytochemicals from the Pandora’s Box". En New Avenues in Drug Discovery and Bioactive Natural Products, 149–67. BENTHAM SCIENCE PUBLISHERS, 2023. http://dx.doi.org/10.2174/9789815136326123020009.
Texto completoBachar, Sitesh C., A. K. M. Shafiul Kadir, S. M. Riajul Wahab y Abdullah Al Hasan. "Heterocyclic Anti-cancer Compounds Derived from Natural Sources with their Mechanism of Action". En Key Heterocyclic Cores for Smart Anticancer Drug–Design Part I, 1–56. BENTHAM SCIENCE PUBLISHERS, 2022. http://dx.doi.org/10.2174/9789815040074122010004.
Texto completoHaider, Kashif y Mohammad Shahar Yar. "Advances of Benzimidazole Derivatives as Anticancer Agents: Bench to Bedside". En Benzimidazole [Working Title]. IntechOpen, 2022. http://dx.doi.org/10.5772/intechopen.101702.
Texto completoActas de conferencias sobre el tema "Potent anti-cancer agent"
Vakkalanka, Swaroop, Kanthikiran Varanasi, Sridhar Veeraraghavan, Meyyappan Muthuppalaniappan, Gayatriswaroop Merikapudi, Sumalatha Kuppireddi y Srikant Viswanadha. "Abstract 2599: RP3035, a potent cytostatic anti-cancer agent, reduces NCI-H460 tumor growth in mice via inhibition of Orai1". En Proceedings: AACR 102nd Annual Meeting 2011‐‐ Apr 2‐6, 2011; Orlando, FL. American Association for Cancer Research, 2011. http://dx.doi.org/10.1158/1538-7445.am2011-2599.
Texto completoGuo, Peng, Jiang Yang, Marsha Moses y Debra Auguste. "Abstract 4410: An ICAM-1-targeted, Lcn2 siRNA-encapsulating liposome as a potent anti-angiogenic agent for triple-negative breast cancer". En Proceedings: AACR 106th Annual Meeting 2015; April 18-22, 2015; Philadelphia, PA. American Association for Cancer Research, 2015. http://dx.doi.org/10.1158/1538-7445.am2015-4410.
Texto completoTanaka, Nozomu, Yukari Yamada, Akio Fujioka, Keisuke Yamamura, Satoko Ito, Kenichi Matsuo y Teruhiro Utsugi. "Abstract B86: Potent antitumor effect of TAS-102, a novel oral anti-neoplastic nucleoside agent, on both cetuximab-sensitiveKRASwild-type and cetuximab-resistantKRASmutated colorectal cancer cells via trifluorothymidine incorporation into DNA." En Abstracts: AACR-NCI-EORTC International Conference: Molecular Targets and Cancer Therapeutics--Oct 19-23, 2013; Boston, MA. American Association for Cancer Research, 2013. http://dx.doi.org/10.1158/1535-7163.targ-13-b86.
Texto completoPollard, John R. "Abstract IA11: Discovery and characterization of potent and selective inhibitors of ATR kinase as anti-cancer agents". En Abstracts: AACR Precision Medicine Series: Targeting the Vulnerabilities of Cancer; May 16-19, 2016; Miami, FL. American Association for Cancer Research, 2017. http://dx.doi.org/10.1158/1557-3265.pmccavuln16-ia11.
Texto completoWang, Shunyou, Lucy Lan, Mathew Janes, Katti Jessen, Linda Kessler, Jeff Kucharski, Xin Xin Guo et al. "Abstract 3753: Potent anti-tumor activity of mTOR kinase inhibitor in combination with anti-angiogenic agents in preclinical models of renal cell cancer". En Proceedings: AACR 103rd Annual Meeting 2012‐‐ Mar 31‐Apr 4, 2012; Chicago, IL. American Association for Cancer Research, 2012. http://dx.doi.org/10.1158/1538-7445.am2012-3753.
Texto completoIrie, Hiroki, Kei Oguchi, Kimihiro Ito, Yayoi Fujioka, Yuichi Kawai, Tadashi Shimamura, Hikari Araki et al. "Abstract B179: TAS0728, a HER2-selective covalent inhibitor, demonstrates potent antitumor effect as a single agent and in combination with anti-HER2 antibodies in HER2-overexpressed tumor models". En Abstracts: AACR-NCI-EORTC International Conference: Molecular Targets and Cancer Therapeutics; October 26-30, 2017; Philadelphia, PA. American Association for Cancer Research, 2018. http://dx.doi.org/10.1158/1535-7163.targ-17-b179.
Texto completoParab, Mala, Pramodkumar Gupta, Shruti Chandrashekar, Shraddha Shetty, Santosh Chhajed y Debjani Dasgupta. "<em>In silico</em> and <em>in vitro</em> study of benzanilide derivatives as potent anti-cancer agents". En 6th International Electronic Conference on Medicinal Chemistry. Basel, Switzerland: MDPI, 2020. http://dx.doi.org/10.3390/ecmc2020-07699.
Texto completo